Stocks making the biggest moves premarket: Macy's, Meta, Apple, Novartis and more

Premarket trading was mixed, led lower by American Eagle (-15%+) on a 1% comparable-sales decline and Q3 operating-income guidance of $110M-$115M versus $124.3M consensus, and Cooper Companies (-17%) on below-consensus Q4 revenue and EPS outlook. Copper miners Freeport-McMoRan (-7%) and Southern Copper (-6%+) fell as copper retreated from a record high, while AeroVironment gained 5%+ after posting adjusted EPS of $0.59 versus $0.25 expected and $480M revenue versus $456M consensus. Macy's beat Q2 revenue and raised full-year sales, comparable-sales and EPS guidance, though its shares slipped 1.6%.

Analysis

The dispersion argues against a broad risk-on/risk-off read: estimate misses and weak forward frameworks are being punished far more than modest beats are rewarded. For AEO and COO, the key issue is not the single-quarter variance but reduced confidence in near-term earnings conversion; both face a credible 1-3 month de-rating risk if sell-side estimates reset to management’s implied run-rate. AEO’s miss also increases read-through risk for teen/apparel peers ANF, URBN and GPS, although ANF’s higher-income customer mix and stronger brand momentum may limit contagion.

AVAV is the cleaner positive setup because a material revenue outperformance can force a backlog, production-capacity and gross-margin reassessment rather than merely a one-quarter EPS revision. The relevant second-order beneficiaries are defense-electronics and autonomy suppliers, but AVAV’s post-print upside should be conditional on confirmation that growth is funded by durable programs rather than timing of government deliveries. META’s AI narrative is unlikely to change the earnings model until ad-load, targeting or engagement monetization metrics improve; the upgrade-driven move is lower-quality than an estimate revision.

Copper’s pullback after a tariff-linked spike highlights that the marginal price setter may be trade-flow positioning rather than physical demand. FCX and SCCO therefore retain downside beta over days to weeks if inventory builds or Chinese demand data disappoint, but a sustained tariff regime could widen regional premia and ultimately support North American producer realizations over 6-18 months. ENB’s transaction should be evaluated through financing cost, leverage trajectory and regulatory/contract quality; absent clear accretion disclosure, the initial selloff may be justified rather than an automatic dip-buy.

KNTK is an event-driven special situation, not yet a fundamental long: strategic interest could expose the scarcity value of Permian gathering assets, but a process without a buyer can unwind quickly. The contrarian opportunity is in selectively owning companies with verifiable upward estimate revisions, rather than chasing the largest premarket percentage moves.

Key Decisions for Investors

• Initiate a 1-3 month long AVAV position only if management reiterates full-year revenue/margin guidance and backlog conversion supports the beat; target a 10-15% upside from post-earnings estimate revisions, with a 7-8% stop if guidance or funded-program commentary weakens.
• Use AEO as a tactical short versus long ANF or URBN for the next 1-2 months. The thesis is relative estimate compression and promotional-margin risk at AEO; cover if AEO’s next sales update shows comp stabilization or if the relative spread widens by roughly 12-15%.
• Do not buy FCX or SCCO into the initial copper decline. Set an alert for a further 8-10% copper correction combined with stable Chinese credit/import data; that combination would offer a better 6-12 month entry for FCX, whose U.S. production profile may gain relative value under durable tariff segmentation.
• Treat KNTK as an event watch rather than a core position: a small long is appropriate only after confirmation of a formal strategic process or credible bidder involvement. Size for deal-break risk; absent confirmation within 30-45 days, exit because standalone valuation support may not sustain speculation.
• Avoid adding ENB until management quantifies debt-funded acquisition accretion, leverage and distribution coverage. A widening credit spread or a leverage-guidance increase would falsify a dip-buy thesis; disclosed accretion with no leverage slippage would justify reassessment.